Literature DB >> 14687390

Sarcopenia: alternative definitions and associations with lower extremity function.

Anne B Newman1, Varant Kupelian, Marjolein Visser, Eleanor Simonsick, Bret Goodpaster, Michael Nevitt, Stephen B Kritchevsky, Frances A Tylavsky, Susan M Rubin, Tamara B Harris.   

Abstract

OBJECTIVES: To compare two sarcopenia definitions and examine the relationship between them and lower extremity function and other health related factors using data from the baseline examination of the Health Aging and Body Composition (Health ABC) Study.
DESIGN: Observational cohort study.
SETTING: Two U.S. communities in Memphis, Tennessee, and Pittsburgh, Pennsylvania. PARTICIPANTS: Participants were aged 70 to 79 (N=2984, 52% women, 41% black). MEASUREMENTS: Participants were assessed using dual energy x-ray absorptiometry and were classified as sarcopenic using two different approaches to adjust lean mass for body size: appendicular lean mass divided by height-squared (aLM/ht2) and appendicular lean mass adjusted for height and body fat mass (residuals).
RESULTS: These methods differed substantially in the classification of individuals as being sarcopenic, especially those who were more obese. The former method was highly correlated with body mass index and identified fewer overweight or obese individuals as sarcopenic. In both men and women, none of the obese group would be considered sarcopenic using the aLM/ht2 method, compared with 11.5% of men and 21.0% of women using the residuals method. In men, both classifications of sarcopenia were associated with smoking, poorer health, lower activity, and impaired lower extremity function. Fewer associations with health factors were noted in women, but the classification based on both height and fat mass was more strongly associated with lower extremity functional limitations (odds ratio (OR)=0.9, 95% confidence interval (CI)=0.7-1.2 for low kg/ht2; OR=1.9, 95% CI=1.4-2.5 for lean mass adjusted for height and fat mass).
CONCLUSION: These findings suggest that fat mass should be considered in estimating prevalence of sarcopenia in women and in overweight or obese individuals.

Entities:  

Mesh:

Year:  2003        PMID: 14687390     DOI: 10.1046/j.1532-5415.2003.51534.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  333 in total

1.  Sarcopenic indices in community-dwelling older adults.

Authors:  Ericka N Merriwether; Helen H Host; David R Sinacore
Journal:  J Geriatr Phys Ther       Date:  2012 Jul-Sep       Impact factor: 3.381

2.  Designing Phase II B trials in sarcopenia: the best target population.

Authors:  M Pahor; M Cesari
Journal:  J Nutr Health Aging       Date:  2011-08       Impact factor: 4.075

3.  Regional muscle and whole-body composition factors related to mobility in older individuals: a review.

Authors:  Jason Kidde; Robin Marcus; Lee Dibble; Sheldon Smith; Paul Lastayo
Journal:  Physiother Can       Date:  2009-11-12       Impact factor: 1.037

4.  Evaluation of the Usefulness of Consensus Definitions of Sarcopenia in Older Men: Results from the Observational Osteoporotic Fractures in Men Cohort Study.

Authors:  Peggy M Cawthon; Terri L Blackwell; Jane Cauley; Deborah M Kado; Elizabeth Barrett-Connor; Christine G Lee; Andrew R Hoffman; Michael Nevitt; Marcia L Stefanick; Nancy E Lane; Kristine E Ensrud; Steven R Cummings; Eric S Orwoll
Journal:  J Am Geriatr Soc       Date:  2015-10-27       Impact factor: 5.562

5.  Letter to the editor: RE: Comments Referring to the Article «Comprehensive Nutritional Status in Sarco-Osteoporotic Older Fallers».

Authors:  J Z Ilich; O J Kelly
Journal:  J Nutr Health Aging       Date:  2016-02       Impact factor: 4.075

6.  Sarcopenia and the New ICD-10-CM Code: Screening, Staging, and Diagnosis Considerations.

Authors:  Laura J Falcon; Michael O Harris-Love
Journal:  Fed Pract       Date:  2017-07-09

7.  DESIGNING DRUG TRIALS FOR SARCOPENIA IN OLDER ADULTS WITH HIP FRACTURE - A TASK FORCE FROM THE INTERNATIONAL CONFERENCE ONFRAILTY AND SARCOPENIA RESEARCH (ICFSR).

Authors:  B Vellas; R Fielding; R Miller; Y Rolland; S Bhasin; J Magaziner; H Bischoff-Ferrari
Journal:  J Frailty Aging       Date:  2014

8.  Incidence of sarcopenia and dynapenia according to stage in patients with idiopathic Parkinson's disease.

Authors:  Tamer Yazar; Hülya Olgun Yazar; Emel Zayimoğlu; Soner Çankaya
Journal:  Neurol Sci       Date:  2018-05-12       Impact factor: 3.307

9.  Respiratory Muscle Strength as a Discriminator of Sarcopenia in Community-Dwelling Elderly: A Cross-Sectional Study.

Authors:  D G Ohara; M S Pegorari; N L Oliveira Dos Santos; C de Fátima Ribeiro Silva; R L Monteiro; A P Matos; M Jamami
Journal:  J Nutr Health Aging       Date:  2018       Impact factor: 4.075

Review 10.  Diagnostic imaging of osteoporosis and sarcopenia: a narrative review.

Authors:  Carmelo Messina; Gabriele Maffi; Jacopo Antonino Vitale; Fabio Massimo Ulivieri; Giuseppe Guglielmi; Luca Maria Sconfienza
Journal:  Quant Imaging Med Surg       Date:  2018-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.